Age-adjusted baseline D-dimer predicts thrombotic events during readmission in anticoagulated patients with non-valvular atrial fibrillation
Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Background Patients with non-valvular atrial fibrillation (NVAF) remain at substantial risk of thrombotic and bleeding events despite oral anticoagulation, and readmission is a common and costly consequence. D-dimer reflects persistent coagulation and fibrinolysis activation and has been associated with adverse outcomes in atrial fibrillation, but whether a single baseline measurement can predict events during readmission remains unclear. Methods We retrospectively studied 1,108 anticoagulated patients with NVAF who had multiple hospitalisations at our institution between 2018 and 2022. Patients were stratified by baseline D-dimer according to an age-adjusted cut-off. The primary endpoint was a composite of thrombotic events, major bleeding and death during readmission, adjudicated by a hierarchical first-event rule. Multivariable Cox regression was performed in the 899 patients with complete CHA₂DS₂-VASc and HAS-BLED scores. Sensitivity analyses included propensity score matching (230 pairs) and a competing-risk model and a 30-day landmark analysis. The incremental value of the age-adjusted D-dimer cut-off beyond CHA₂DS₂-VASc was assessed by the C-statistic. Results The abnormal-D-dimer group had a higher incidence of the composite endpoint (24.0% vs 9.6%, P < 0.001) and of thrombotic events (19.7% vs 8.2%, P < 0.001). Abnormal D-dimer independently predicted the composite endpoint (adjusted HR 1.64, 95% CI 1.09–2.47) and thrombotic events (adjusted HR 2.02, 95% CI 1.30–3.15), but not major bleeding (HR 1.46, 95% CI 0.44–4.90) or death during readmission (HR 1.73, 95% CI 0.54–5.52). Sensitivity analyses were consistent for the composite and thrombotic endpoints, whereas bleeding and death events were too few for reliable estimates. Adding D-dimer to CHA₂DS₂-VASc improved discrimination (ΔC = 0.034, 95% CI 0.006–0.076) and reclassification (24-month NRI = 43.8%; IDI = 0.025). Conclusions In anticoagulated patients with NVAF, a baseline D-dimer above the age-adjusted cut-off independently predicts thrombotic events during subsequent readmission and provides incremental predictive information beyond CHA₂DS₂-VASc.
Source: Research Square
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7225869156
